Navigation Links
Omni Bio Pharmaceutical Intends to Expand Type 1 Diabetes Trial to 50 Patients
Date:2/28/2011

DENVER, Feb. 28, 2011 /PRNewswire/ -- (OTC Bulletin Board: OMBP) Omni Bio Pharmaceutical, Inc. ("Omni Bio"), an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.

The expansion of the trial population has been approved by the FDA.  The trial, which is currently underway at the Barbara Davis Center for Childhood Diabetes ("BDC") at the University of Colorado-Denver Anschutz Medical Campus, has seen improvement in the condition of the first enrolled patients.  Based on observations of the first enrolled patients at BDC, Omni Bio intends to expand the patient enrollment to 50 patients, which may involve obtaining a second trial site.

Dr. James Crapo Omni Bio's Chief Executive Officer stated, "We are currently engaged in discussions related to expanding our Type 1 diabetes trial from the initially targeted 15 patients to a total of 50 patients.  The expansion of the trial will cause a substantially greater amount of statistically relevant scientific data to be generated, allowing us to better assess our next steps in pursuing this indication."

The expansion of the clinical trial would result in an increase of clinical trial service costs of approximately $2 million, excluding drug costs, and would require Omni Bio to raise additional financing before the expansion of the trial can begin.  There is no assurance that Omni Bio will be able to raise additional capital to fund the expansion of the clinical trial on acceptable terms or at all.

Omni Bio is also pleased to announce that it has received letters of intent for human clinical trials at a number of institutions in the United States and Europe, contingent
'/>"/>

SOURCE Omni Bio Pharmaceutical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- SAM ... (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that ... recall to address a potential issue with a ... for the Axilla application of the SAM Junctional ...
(Date:8/29/2014)... , Aug. 29, 2014  A Boston ... multinational study on stent removability and preliminary long ... been published in the August issue of the ... study 1 is being conducted in 11 ... fully covered self-expanding metal stents (FCSEMS) after extended ...
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... , ARDEE, Ireland, Dec. 11 As ... disclosed, its acquisition of the global branded prescription pharmaceuticals ... October 30, 2009 (the "PGP Acquisition"), constituted a change ... (the "Marketing Agreement") between a P&G subsidiary acquired by ...
... , BATESVILLE, Ind., Dec. 11 ... Hill-Rom,s Advanta(TM) 2 Bed for use in medical-surgical areas of hospitals and ... safety features and the flexibility to use a variety of care surfaces ... to our customers. It combines the best features of Hill-Rom,s long-time leader, ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4
(Date:8/30/2014)... UWDress.com, a distinguished wedding dress supplier, has gained a great ... outfits. Recently, the company has unveiled its beautiful collection of ... offer, all these brand new products are provided with big ... excited to unveil the new and trendy bridesmaid outfits and ... available at low prices now. The purpose of our company ...
(Date:8/30/2014)... Recently, iFitDress.com, one of the most ... of classy bridesmaid dresses . For additional information, ... percent off to 62 percent off) for all people ... , True enough, iFitDress.com is an industry leader ... The company persists in making trendy products that can ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The Truth about ... body that will reveal to users some shocking foods that ... great results in modeling looks, as well as some motivation ... method says that there is one unique trick that can ... indicates that despite what many people might think, cardio exercise ...
(Date:8/30/2014)... 2014 Fast hosting is a ... has recently compared many professional web hosting suppliers ... and Arvixe are the suppliers of fastest web ... find a good fast hosting supplier. Actually, these ... uptime, server speed and customer support. People can ...
(Date:8/30/2014)... 2014 According to Bloomberg , ... requires Takeda Pharmaceutical Co. and Eli Lilly & Co. ... that the drugmakers concealed information about a risk of ... case, Allen v. Takeda Pharmaceuticals North America Inc. (12-cv-00064), ... of Louisiana (Lafayette).* , According to Bloomberg, Takeda and ...
Breaking Medicine News(10 mins):Health News:UWDress.com’s Beautiful Collection Of “Flowy Bridesmaid Dresses” Released 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2
... Israel, Nov. 21 Shamir,Optical Industry Ltd. (Nasdaq: ... earnings results on Tuesday, November 27, 2007, and has,scheduled ... A.M. EST that,morning., The conference call will be ... go to http://www.kcsa.com approximately five minutes before,the ...
... 2007 Full-Year Financial Outlook, WOODCLIFF LAKE, N.J., Nov. ... today filed with the U.S.,Securities and Exchange Commission (SEC) ... 2007. The filing of Par,s Form 10-Qs for these ... restating its consolidated,financial statements for certain prior periods, which ...
... Open access online journal,AZoJono* (The AZo Journal ... research edition in conjunction with DESYGN-IT*, an ... investigating the design,synthesis, growth and application of ... URL for special edition,[ http://www.azonano.com/nanotechnology%20journal.asp ...
... 20 CHF,International has been selected as the ... Fund) new Principal Recipient (PR) for,HIV/AIDS prevention, treatment ... awarded an HIV proposal in Round 3 programming., ... years, CHF will be directly responsible for,managing Honduras, ...
... S.C., Nov. 20 BlueCross BlueShield of ... awarded Case Management,Accreditation from URAC, a Washington, ... standards for the health care,industry. URAC,s ... a process to assess, plan and implement ...
... 20 2007 Vase or face" When presented with the well ... the faces of two people, what we observe depends on the ... , In this example, whether you see faces or vases depends ... always stays exactly the same, said John Serences, a UC Irvine ...
Cached Medicine News:Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results 2Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 2Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 3Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 4Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 5Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 6Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 7Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 8Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 9Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 10Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 11Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 12Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 13Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 14Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 15Health News:Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech Journal 2Health News:CHF International Named Global Fund Principal Recipient in Honduras 2Health News:S.C. BlueCross BlueShield Receives URAC Case Management Accreditation 2Health News:Scientists uncover how the brain controls what the eyes see 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: